The median dose of this other insulin glargine product at end of trial was 0.45 U/kg
Small steps, like getting outside and being active every day, can boost your metabolism, lift your mood, and enhance your sleep
Inspection of the trajectory of weight changes with time revealed that weight loss continued to progress in the CagriSema group up to the end of treatment at 32 weeks, whereas in the semaglutide and cagrinlitide groups, weight reduction seemed to approach a plateau [10]
If pain is constant, progressive, or keeps returning, it needs evaluation
Understanding these clinical manifestations is critical for guiding diagnostic strategies, selecting appropriate treatments, and optimizing reproductive outcomes for affected women ( Figure 2 )
No, GLP-1s are used for type 2 diabetes and (for specific products/indications) chronic weight management